Herborium’s all-natural, herbal energy drinks expected this fall
Herborium Group announced today that its proprietary energy drinks, which contain all herbal ingredients, will hit the market this fall and will complement the company’s sexual health product line.
Herborium’s energy drinks are all-natural and contain caffeine, sugar and B vitamins in safe amounts, according to the company. The $8 billion energy drink segment is the fastest-growing niche in the beverage market, according to Herborium, up 16% since last year.
"We are extremely excited to move into the commercialization stage for our unique healthy energy product that can also fight jet lag and has no adverse effects," said Agnes Olszewski, chairman and CEO of Herborium. "Our product contains a proprietary blend of herbal extracts that provide for an immediate lift of energy and alertness as well as for longer lasting beneficial effects, without jittery feeling and a ‘crash’ associated with caffeine and sugar containing drinks."
Health IT pilot aims to curb Rx drug abuse
WASHINGTON — A new pilot program that aims to curb prescription drug abuse among patients will be tested in Indiana and Ohio.
Created by the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology, the projects — funded by the Substance Abuse and Mental Health Services Administration and managed by ONC in collaboration with SAMHSA, the Centers for Disease Control and Prevention and the Office of National Drug Control Policy — will measure the effects of expanding and improving access to prescription drug monitoring programs and are part of the Obama administration’s comprehensive efforts to reduce the prescription drug abuse epidemic.
The pilot project in Indiana will demonstrate how emergency department staff can receive a patient’s controlled substance prescription history directly through the Regenstrief Medical Record System, a care management system used by Wishard Health Services — a community health system in Indianapolis — and other hospitals. The project is a collaboration between ONC, Regenstrief, Wishard, the National Association of Boards of Pharmacy, Appriss and the state of Indiana.
Meanwhile, the Ohio pilot project will test the impact of having a drug risk indicator in the electronic health record and how that affects clinical decision making. The Ohio project is a collaboration with the Springfield Center for Family Medicine, Eagle Software Corp.’s NARxCHECK, the state of Ohio and MITRE.
"Technology plays a critical role in our comprehensive efforts to address our nation’s prescription drug abuse epidemic," said Gil Kerlikowske, director of National Drug Control Policy. "Together with education, proper disposal practices, and enforcement, improving existing prescription monitoring programs is a priority for this administration. We hope these innovative pilots will help usher in an era of ‘PDMPs 2.0’ across the nation to improve real-time data sharing among, increase interoperability of data among states, and expand the number of people using these important tools."
Makucell launches anti-aging skin care brand with innovative new technology
Makucell — a regenerative biotechnology company that develops, manufactures and distributes anti-aging skin care — has unveiled its new Renewnt brand. The product line uses a proprietary ingredient known as Asymmtate, which the company said energizes the skin’s stem cells, encouraging youthful cell behavior for firmer and smoother skin.
Asymmtate technology was developed at University of Southern California’s Keck School of Medicine and transferred to Makucell’s Renewnt skin care line. The technology encourages optimal signaling in the body’s Wnt signal pathway, thereby stimulating the skin stem cells to begin the process leading to keratinocytes, fibroblasts and other dermal cells, which produce collagen, elastic tissue and substances in the supporting skin matrix.
According to the company, Renewnt products:
Penetrate into viable skin;
Are not irritating or sensitizing;
Show measurable up-regulation of genes that express skin structural proteins with simultaneous down-regulation of inflammatory genes in gene expression analysis; and
Perform well in clinical studies. Skin shows smoothing, plumping and an improvement in texture after as little as four weeks.
“Makucell is committed to supporting our claims with results from controlled, blinded studies,” explains Dr. Mark Dahl, Makucell chief medical officer and former president of the American Academy of Dermatology. “We conducted standard industry safety tests, and the results were universally positive; Renewnt products were well tolerated with no adverse effects or safety issues. A combination of clinical trials and in vitro gene expression studies from treated biopsied skin continues to corroborate the aesthetic effects noted in the clinic.”
Makucell’s current Renewnt skin care products include:
Renewnt for Hydration, a day and night facial moisturizer for a more youthful-looking appearance;
Renewnt for Strength, for the dry, thinning skin on hands and forearms to seal in moisture, repair the signs of aging and restore the essential skin barrier;
Renewnt for Firmness, a neck and décolletage cream hydrates and improves elasticity, reduces wrinkles and roughness, and visibly increases firmness; and
Renewnt for Brightness, a serum to address irregular skin pigmentation and sun damage to lighten and even skin color.